Post-Pandemic Resiliency: The Shift Toward Domestic Outsourcing
The global health crisis of the early 2020s exposed the vulnerabilities of overly extended supply chains, leading many European pharmaceutical companies to rethink their outsourcing strategies. There is a growing trend toward "nearshoring" or domestic outsourcing, where trials are kept within Europe rather than being moved to lower-cost regions in Asia. This shift is driven by a desire for...
0 Commentaires
0 Parts
1000 Vue
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt